In the context of the cancer treatment approaches, the computational findings proposed that EGFR, MAPK3, CCND1, FGF2, CHEK1, VEGFA, RELA, and ERBB3 have potential efficacy biomarkers for BC. This evidence concerns the gene ERBB3 and breast cancer.